Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_37_библиотеки_им_акад_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
17 Мб
Скачать
☆
CHAPTER 7 Physiologic Monitoring
V
˙
Q
https://t.me/medicina_free
179
weights and postnatal ages.2 Pulse oximetry saturation (SpO2) values vary significantly from measured
arterial tension values obtained with an arterial blood gas specimen.37 A contributing factor may
be that the calibration of pulse oximeters typically has been performed on healthy adults. A compel­ling argument for the use of both pulse oximetry and transcutaneous oxygen monitoring in critically ill infants can be made because each monitor has its own shortcomings.
Pulse oximetry monitoring is common in neo­natal care. Many infants in NICUs require pro­longed monitoring, and a long-lasting oximeter probe could offer a substantial cost savings. No
complications are associated with the use of oxygen saturation monitoring other than the potential for skin trauma caused by adhesive on the probe. Newer probes held in position by
gentle elastic pressure have no adhesive touching the infant’s skin.
In the asymptomatic newly born infant, the inci­dence of congenital heart anomalies is approximate­ly 1% to 2% of live births, with one-fourth of these having critical congenital heart defects (CCHDs). CCHD lesions are ductal dependent or require car­diac catheterization or surgery before 1 year of age, with most requiring intervention within the first month. If not detected early, organ hypoperfusion and hypoxemia occur as the infant continues to tran­sition to adult circulation. Detection of CCHDs
before discharge allows medical and surgical interventions that may be lifesaving. Multiple
organizations in the United States
25,41,42
ly
have recommended routine screening of all
10,24
and global-
infants after 24 hours of life and before discharge. In 2011, the U.S. Department of Health and Human Services (USDHHS) added screening for CCHDs to the Recommended Uniform Screening Panel.48 The American Academy of Pediatrics endorsed the USDHHS recommendation.23 Refer to a full dis­cussion in Chapter 31.
Noninvasive Oxygen–Carbon Dioxide Monitoring
END-TIDAL CARBON DIOXIDE MONITORING
End-tidal CO2 monitors use either sidestream or
mainstream analysis. For sidestream analysis, the endotracheal tube has a second narrow lumen that opens at the end of the endotracheal tube. Gases
are analyzed from samples taken from the end of the tube. The advantages of this system are that
there is no increased dead space in the ventilator circuit and less chance of inspiratory gases con­taminating the sample. The disadvantage to this
method is that secretions may pool at the tip of the endotracheal tube and occlude the sampling port. The response time to changes in carbon dioxide content is slower than when mainstream analysis is used.
Mainstream analysis of carbon dioxide sam-
ples gases in the ventilator circuit. These gases
are thought to be reflective of gases at the tip of the endotracheal tube. This method requires a sepa-
rate chamber attached to the end of the endo­tracheal tube adapter, thus adding increased dead space and additional weight at the endo­tracheal tube adapter.
A comparison of sidestream and mainstream analyses of end-tidal CO2 found that distal values were higher than proximal values and that distal values correlated more closely with PaCO2 values.47 This discrepancy was thought to result from the mixing of end-tidal gases with fresh gases in the ventilator circuit. In an infant with a large alve-
olar-arterial (A-a) gradient, PetCO2 monitoring cannot be relied on for accuracy. In premature infants, it may be useful if the lung disease is mild to moderate; in infants with normal lung function, this method is reliable.
45
The waveform output of the end-tidal CO2 monitor can be used clinically if the clinician understands how the waveform corresponds to the exchange of gases in the lung (see Fig. 7.2) .
The waveform has a sharp rise on expiration that reflects the carbon dioxide content of various lung areas. This expiration is followed by a plateau that reflects the cessation of dead space gases and the measurement of alveolar gas. At the end of the plateau is a sharp drop that reflects the inspiration of fresh gases with minimal carbon dioxide content. When using
the monitor, the clinician should recognize that a sharp rise indicates compromised exhalation, such as in reactive airway disease. Partially plugged and
dislodged endotracheal tubes will change the angle of rise on the capnogram. The plateau
phase of the capnogram can be altered by severe hypotension or decreased cardiac output secondary to an altered minute ventilation-perfusion (
˙
/
)
mismatch (as in pulmonary embolus, cardiac arrest,
180 UNIT TWO Support of the Neonate
https://t.me/medicina_free
persistent pulmonary hypertension, atelectasis). No
waveform or failure of the waveform to change indicates ineffective respiration (dislodged endo­tracheal tube).
TRANSCUTANEOUS OXYGEN–CARBON
DIOXIDE MONITORING
Skin oxygen tension (TcPO2) and carbon dioxide tension (TcPCO2) are measured by using one or two electrodes, depending on the model and brand of the monitor. The electrodes, once positioned on the skin, heat the area under the probe and cause certain physiologic changes as discussed. Oxygen
and carbon dioxide that diffuse through the heated skin are measured by the electrode, and the value is digitally displayed on the monitor. If intervals between calibration are longer than 4 hours, the readings are subject to drift. The cal-
ibration procedures vary with the instruments used. Inherent in the calibration process is the necessity to change the position of the skin electrode on the infant. Better correlations are found when the
instrument is calibrated every 4 hours, the tem­perature is set correctly, and the infant is well perfused and normothermic. If the temperature of the probe cannot be maintained at 43°C to 44°C (109.4°F to 111.2°F), a lower temperature should be selected to avoid possible burns. At a
lower temperature, the TcPO2 monitor can be used to monitor trends but should not be interpreted as actual PaO2 values. The range of accuracy of TcPO2 monitors is limited; hypoxia (less than 40 mm Hg) and hyperoxia (greater than 120 mm Hg) may not be accurately reflected.
In an infant with suspected significant right­to-left shunting through a patent ductus arteriosus such as in persistent pulmonary hypertension, two transcutaneous oxygen electrodes can be used: one preductally (right shoulder) and the other postduc­tally (lower abdomen or legs). Significant right-to­left shunting through the patent ductus arteriosus is present when the preductal oxygen tension is significantly higher than the postductal oxygen tension.
The disadvantages of the use of transcutane­ous monitoring are that the instrument requires frequent calibration; requires the use of a heated electrode, which may burn the skin, especially in low-birth-weight (LBW) infants; requires a 15-min­ute period after calibration to heat the skin to the correct temperature; and has a 15- to 20-second
delay in the readings compared with the patient’s real-time values. The advantages are that it is not invasive, does not require the removal of blood for analysis, and displays a continuous readout of skin oxygen–carbon dioxide tensions.
NURSING CARE OF INFANTS WITH NONINVASIVE TRANSCUTANEOUS OXYGEN AND CARBON DIOXIDE MONITORS
The electrode can be placed on any portion of the infant’s body as long as good contact between the electrode and the skin is main­tained. Uneven areas of skin such as over bones and
joints should be avoided because of poor contact between the membrane and the skin surface. The infant should not lie on the electrode. Placing the infant on top of the electrode increases the pressure on the underlying capillaries, thus affecting the flow of blood under the probe and resulting in a drop in TcPO2 values. Because of the heat generated
by the electrode (43°C to 44°C [109.4°F to
111.2°F]), small red areas resembling first-de­gree burns are produced on the infant’s skin. To minimize trauma to the infant’s skin, the electrode should be repositioned every 2 to 4 hours, depending on his or her skin sensitivi­ty. Grouping of nursing interventions has resulted
in minimizing the time that the infant receives less-than-optimal oxygenation.
Cardiorespiratory Monitoring
The chest leads are applied in a triangular pat­tern on the infant’s chest. Integrity of the leads must be ensured. Allowing the contact gel to dry
or inadvertently dislodging the lead during proce­dures such as x-ray examination, echocardiography, and lumbar puncture may account for inaccurate tracings. Various components of the electrocardio­gram (ECG) pattern may be diagnostically helpful. The QRS complex should be monitored for base­line height and width. A sudden decrease in QRS
complex height that is not caused by artifact may be an indication of pneumothorax. The
QT interval is helpful in diagnosing hypocalcemia in some infants. Other portions of the strip may be evaluated for electrolyte imbalance and possible cardiac ischemia. Hyperkalemia can induce arrhyth­mias, including heart block, ventricular tachycardia and fibrillation, and asystole. Initially the ECG will
CHAPTER 7 Physiologic Monitoring
https://t.me/medicina_free
181
show peaked T waves with a narrow base. As the potassium level rises, the P dampens, the PR interval increases, and the QRS widens. Further increases in the potassium value lead to absent P waves, QRS merging with the T wave to form a sine wave, fol­lowed by fibrillation, and then asystole.
Humans display variability in vital signs because of the constant adjustments by the sympathetic and parasympathetic nervous systems. Vital sign variability in the healthy infant is maintained near a baseline value. When stressful events such
as late-onset sepsis, intraventricular hemorrhage, or severe chronic lung disease are present, there is a cor­responding change in vital signs and diminution in variability. Infants developing late-onset infection may exhibit subtle, nonspecific signs in advance of a clinical diagnosis. To aid in detecting heart rate changes that may indicate developing infection, some NICUs now use the HeRO system (Medical Predictive Sciences, Charlottesville, VA). Heart rate changes over a 5-day period are tracked allowing health care personnel to follow patient trends. Loss of beat-to-beat variability
and rising heart rate warrant investigation. As with
any instrument, use of this device requires patient assessment and judgment.
19
27
to ensure proper diagnosis and treatment, and the CLIA regulations strive to ensure quality testing.
The accuracy of whole blood glucometers com­pared with laboratory values may vary depending on hypoxia, hematocrit, and elevated triglyceride values. Accuracy also depends on the product that is being measured, because some glucometers measure glucose only, whereas others measure total sugars, including glucose, galactose, maltose, and xylose. In addition, the clinician must remember that an
approximately 11% difference exists between plasma glucose (laboratory sample) and whole­blood glucose (POCT device). The POCT value should be multiplied by 1.11 to determine a more approximate plasma value.13 A variance
of accuracy also exists with bedside electrolyte assessment devices. Transcutaneous neonatal bilirubin assessments require correlation between the serum bilirubin value and each device, institution, and patient population for which it is used.11 As neonatal care advances, rapid availability of patient information will become more and more crucial. Expect continu­ous expansion of POCT.
Event Monitoring
Blood Pressure Monitoring
Arterial pressure monitoring may be accomplished via the UAC attached to a transducer and mon­itor. Central venous pressure monitoring may be carried out in the same manner using the UVC.
The same type of transducer may be used for either arterial or venous pressure recording.
Some research has indicated that the predictive value of peripheral blood pressure screening for CCHD is small and that oscillator blood pressure measurements are less accurate than pulse oximetry screening to detect CCHD.5 This failure to detect CCHD is more pronounced in aortic arch obstruc­tive defects.
Point-of-Care Testing
The Centers for Medicare and Medicaid Services
regulates POCT through the Clinical Laboratory Improvement Act (CLIA).9 Federal regulations
require initial education about POCT proce­dures, as well as annual reassessment of com­petency. The quality of these tests is imperative
The advancement of physiologic monitors with
memory capability has enhanced the ability of the practitioner to review the physiologic status of
the infant as measured by multiple physiologic parameters for the past 24 to 48 hours. In many
NICUs, the monitor output is integrated into the electronic or computerized chart. This integration allows the care provider to retrieve the data from the monitors into the chart at preselected times, either prospectively or retrospectively. When the
monitors are programmed with critical value ranges, any deviation outside these ranges is noted as an event, which can then be reviewed, tallied, or otherwise annotated. For care providers
at the bedside, the challenge is to keep iatrogenic events (e.g., lead removal, excessive activity of the infant, a stopcock turned the wrong direction) minimized such that the infant’s record is as valid a reflection of actual physiologic status as possible. Any circumstances noted at the time of the event that may produce false readings should be recorded so that when the infant’s record is reviewed, these events can be placed in context of the circumstances at the time.
182 UNIT TWO Support of the Neonate
https://t.me/medicina_free
BOX
7.1
• Umbilical artery catheters
• Ischemia from thrombi, emboli, or arterial spasms
• Hemorrhage caused by catheter dislodgement or loose connec-
• Infection
• Malposition
• Umbilical vein catheters
• Thrombus formation leading to pulmonary embolization
• Thrombus formation in portal vessels
• Hepatic necrosis
• Intestinal ischemia
• Hemorrhage caused by catheter dislodgement or loose connections
• Cardiac complications: dysrhythmias, myocardial perforation,
• Infection
• Peripherally inserted central catheter lines
• Occlusion
• Clotting
• Infection
• Malposition
• Cardiac complications: dysrhythmias, myocardial perforation,
• Breakage and leaking
• Phlebitis
• Peripheral edema
• Vascular erosion into the pleural space
CRITICAL FINDINGS
COMPLICATIONS OF INDWELLING CATHETERS
tions
pericardial effusion
pericardial effusion
4
COMPLICATIONS
UACs act as foreign bodies, causing fibrin depo-
sition and thrombus formation around the cath­eter. Although most catheters are associated with thrombus formation, it is of clinical significance in less than 10% of patients (Box 7.1). A common
problem associated with major complications of UACs is ischemic disease resulting from emboli or arterial spasms. In such cases, the catheter should be removed immediately and antithrombin therapy should be considered.
Although vasospasm is common, usually it does not require immediate removal of the catheter.
Blue discoloration, commonly called “catheter toes,” is seen, rather than blanching. Obviously,
a hemorrhage may occur when the catheter slips out or when any of the various connec­tions loosen. For reasons such as these, UACs require constant attention. If the lower extrem­ities or buttocks blanch, the catheter should be removed immediately and antithrombin therapy considered. The benefit of antithrombin
therapy must be balanced against the increased risk for intracranial hemorrhage.
To prevent bleeding once the catheter is removed, immediately pinch the subumbilical area with sterile gauze for 5 minutes until hemo­stasis is achieved. Avoid downward abdomi-
nal pressure that may compromise respiratory effort. When the color has returned to the
affected area and the infant is stable, replacement of the catheter can be considered. If vasospasm
occurs in one leg or foot, apply warm wraps (diapers wetted with warm water or chem­ical heel warmers) to the opposite leg, or apply wraps to the upper extremities, thereby producing a reflex vasodilation to the legs. However, inherent in this action is the hazard of obscuring recognition of compromise in that extremity. The wraps should be reheated every 10 to 15 minutes until the spasm has resolved. The skin temperature of the infant must be greater than 36°C (96.8°F) for wraps to be effective.
UVCs may cause thrombus formation.
Thrombi can result in pulmonary embolisms. Clots may form in the portal vessels, resulting in portal hypertension. Hepatic necrosis, gut ischemia, and hemorrhage have been associated with UVCs. Other complications include dysrhythmias, myo­cardial perforation, pericardial effusion, and endo­carditis.
PICCs that are placed in central veins have complication rates lower than those placed in noncentral veins.51 Complications include occlu-
sion, clotting, infection, sepsis, phlebitis, leakage, extravasation, peripheral edema, malposition, cath­eter migration, cardiac tamponade, and catheter breakage.52 Bacteremia, always a major con-
cern, will require the removal of the catheter if the blood culture remains positive for more than 24 hours. To prevent central line–associ­ated bloodstream infection (CLABSI), estab­lishment of and strict adherence to a care bundle is beneficial.8 Bundle items for insertion
include a procedure cart with sterile perimeter,
CHAPTER 7 Physiologic Monitoring
https://t.me/medicina_free
183
skin disinfection, and strict sterile technique. Maintenance items include handwashing, use of gloves, attention to PICC access and fluid tubing changes, and daily CLABSI surveillance. Refer to a full discussion in Chapter 16. Occlusion some­times may be treated with clot-dissolving agents. Establishment of a PICC team to insert and man­age these devices, catheter tip placement in the superior or inferior vena cava, and heparinized solutions have been shown to reduce complica­tions. In an emergent situation, evaluate catheter tip placement before administering medications or fluid boluses in case of catheter malposition and cardiac tamponade.
CONTROVERSIES
Clinicians continue to disagree on the optimal placement site for UACs. However, a Cochrane review and subsequent update determined that
high UACs resulted in fewer vascular compli­cations than did low UACs and recommended the exclusive use of high placement for UACs.3
Prophylactic administration of antibiotic agents is not indicated.33 Use of the UAC for infusion of antibiotic agents, calcium, hyperalimentation solu­tions, or blood varies, and no definitive studies are available. Blood cultures can be drawn from the UAC for up to 6 hours after insertion. The use of heparin in the infusate has been controversial because heparin decreases catheter occlusion but not thrombosis.34 In addition, heparin use in a flush solution alone is not beneficial in preventing cath­eter occlusion.
Enteral feeding with an umbilical line in
place lacks definitive studies; however, this prac-
tice is more common than was previously thought. A Cochrane review found that trophic enteral feed­ings were not detrimental.30 Select NICUs pro­vided trophic and more substantial enteral feedings with umbilical catheters in place.
Routine monitoring of all infants receiving
intermediate or intensive care is the standard of care. Indwelling catheters for blood pressure mon-
itoring have the advantage of continuous readout, but external cuffs are less invasive. There is a con­tinued need for research into the efficacy and safety of umbilical catheters. Box 7.2 cites new research into future possibilities for neonatal physiologic monitoring.
21
BOX
7.2
1. Intelligent monitoring systems. Rather than signal when a single pa-
2. Telemedicine has demonstrated success in examining and diagnosing
3. Telemedicine to provide follow-up care of newborns discharged from
4. Use of nasogastric tubes to monitor intraabdominal pressure of VLBW
5. Electrode-free, noninvasive wireless vital signs monitoring systems.
6. Artificial womb for preterm infants <26 weeks of gestation.
BOX
7.3
Physiologic Monitoring
1. Placement of umbilical lines is invasive. Educate parents about the
• Placement is painless because the umbilical cord contains no nerves.
• The point of catheter insertion and where the tip of the catheter
• The umbilical catheter can be used for numerous functions: ad-
• Care should be taken when holding or manipulating the infant to
• Holding the infant out of the incubator and wrapped in blankets
2. The NICU environment can be frightening. Educate parents about the
• The baby is being monitored by various methods, including car-
• The purpose and a short description of each monitor.
WHAT’S NEXT IN PHYSIOLOGIC MONITORING?
rameter exceeds a preset threshold, these monitors would integrate multiple data, including patient medications and laboratory results, to provide a more complete view of the patient’s status.
retinopathy of prematurity and genetic and neurologic abnormalities.51 It will now evolve to allow a remote neonatal intensive care unit model where a neonatologist can simultaneously monitor multiple infants continuously—visually and by the integration of multiple data. Virtual rounds as needed, as well as care direction, can occur.
NICU, resulting in a decreased need for hospital visits.
preterm infants (<1500 g) to evaluate for feeding intolerance.
PARENT/CAREGIVER TEACHING
PHYSIOLOGIC MONITORING
following:
is located.
ministering IV fluid, medications, and blood products; monitoring; and obtaining laboratory specimens.
prevent catheter dislodgement and blood loss.
obscures visualization of the catheter and connections.
following:
diorespiratory, blood pressure, and transcutaneous monitors.
2
47,50
37
7
32,44
15,35,49
PARENT TEACHING
Important elements of parent teaching are list­ed in Box 7.3. As with the many other invasive
procedures in neonatology, the clinician obtains
184 UNIT TWO Support of the Neonate
https://t.me/medicina_free
permission from the parents for umbilical vessel catheterization and PICC placement. This may be the clinician’s first contact with the family and thus sets the atmosphere for future contacts. Although parents initially are hesitant about umbilical catheter placement, generally they are comforted to learn that it will result in a painless way of drawing blood; there are no nerves in the umbilical cord to sense pain. Parents also appreciate that PICC placement will reduce the number of peripheral IV attempts.
Before parents visit the infant, providers need to inform parents about the technology that is being used to monitor the infant (i.e., umbilical
catheter, transcutaneous monitors, cardiorespiratory monitors, blood pressure monitors), including what the technology is registering. Often parents are con­fused about where the catheter goes once it enters the umbilicus and the purposes of other monitoring devices.
Parents need to be instructed on how to hold their infant while an umbilical catheter or PICC is in place because manipulating the infant may accidentally dislodge the catheter and result in blood loss and potential infection. When
the infant is being held out of the incubator and wrapped in blankets, the integrity of the catheter and connections is not easily evaluated. The par­ents’ vigilance around the technology used on their infant can potentially avoid these incidents.
REFERENCES
1. Ainsworth SB, McGuire W. Peripherally inserted central cathe-
ters vs peripheral cannulas for delivering parenteral nutrition in
neonates. JAMA. 2016;315(23):2612.
2. Ansermino JM. Intelligent patient monitoring and clinical deci-
sion-making. ASA Monitor. 2011;75(9):20. 3 . Barrington KJ. Umbilical artery catheters in the newborn:
effects of position of the catheter tip. Cochrane Database Syst Rev.
2000;2:CD000505.
4. Blackwood BP, Farrow KN, Kim S, Hunter CJ. Peripherally
inserted central catheters complicated by vascular erosion in
neonates. J Parenter Enteral Nutr. 2016;40(6):890.
5. Boelke KL, Hokanson JS. Blood pressure screening for critical con-
genital heart disease in neonates. Pediatr Cardiol. 2014;35(8):1349.
6. Brew N, Walker D, Wong FY. Cerebral vascular regulation and
brain injury in preterm infants. Am J Physiol Regul Integr Comp
Physiol. 2014;306(11):R773.
7. Carter BM, Howard C. A 6th vital sign—potential use of
nasogastric tube for intraabdominal pressure monitoring method
to detect feeding intolerance in very low birth-weight infants
(<1500 g). Adv Neonatal Care. 2015;15(3):178.
8. Ceballos K, Water man K, Hulett T, Makic MB. Nurse-driven
quality improvement interventions to reduce hospital-acquired
infection in the NICU. Adv Neonatal Care. 2013;13(3):154.
9. Centers for Disease Control and Prevention. Clinical Laborato- ry Improvement Amendments. Available at: wwwn.cdc.gov/clia. Accessed October 1, 2018.
10. Centers for Disease Control and Prevention. Rapid implemen­tation of pulse oximetry newborn screening to detect critical congenital heart defects—New Jersey. MMWR. 2013;62(15):292.
11. Chacko B, Peter JV, Patole S, et al. Electrolytes assessed by point-of-care testing—are the values comparable with results obtained from the central laboratory? Indian J Crit Care Med. 2011;15(1):24.
12. Cheng HY, Lu CY, Huang LM, et al. Increased frequency of peripheral venipunctures raises the risk of central-line associated bloodstream infection in neonates with peripherally inserted central venous catheters. J Microbiol Infect. 2016;49(2):230.
13. D’Orazio P, Burnett RW, Fogh-Anderson N, et al. Approved IFCC recommendations on reporting results for blood glucose. Clin Chem Lab Med. 2006;44(12):1486.
14. Elser HE. Options for securing umbilical catheters. Adv Neonatal Care. 2013;13(6):426.
15. Engelhaupt E. Artificial womb could offer new hope for prema­ture babies. National Geographic. 2017. Available at: https://news.
nationalgeographic.com/2017/04/artificial-womb-lambs-prema­ture-babies-health-science. Accessed October 1, 2018.
16. Fidler HL. The use of bedside ultrasonography for PICC place­ment and insertion. Adv Neonatal Care. 2011;11(1):52.
17. Foglia EE, Whyte RK, Chaudhary A, et al. The effect of skin pigmentation on the accuracy of pulse oximetry in infants with hypoxemia. J Pediatr. 2017;182:375.
18. Franta J, Harabor A, Sotaisham AS. Ultrasound assessment of um­bilical venous catheter migration in preterm infants: a prospec­tive study. Arch Dis Child Fetal Neonatal Ed. 2017;102(3):F251.
19. Hicks JH, Fairchild KD. Heart rate characteristics in the NICU: what nurses need to know. Adv Neonatal Care. 2013;13:396.
20. Hoellering AB, Koorts PJ, Cartwright DW, Davies MW. Determination of umbilical venous catheter tip position with radiograph. Pediatr Crit Care Med. 2014;15(1):56.
21. Howley LW, Kaufman J, Wymore E, et al. Enteral feeding in ne­onates with prostaglandin-dependent congenital cardiac disease: international survey on current trends and variations in practice. Cardiol Young. 2012;22(2):121.
22. Kumar PP, Kumar CD, Nayak M, et al. Umbilical arterial cath­eter insertion length: in quest of a universal formula. J Perinatol. 2012;32(8):604.
23. Mahle WT, Martin GR, Beekman RH 3rd, et al. Endorsement of Health and Human Services recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics. 2012;129(1):190.
24. Mahle WT, Newburger JW, Matherne GP, et al. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP. Pediatrics. 2009; 124(5):823.
25. Manzoni P, Martin GR, Sanchez Luna M, et al. and the Euro­pean Pulse Oximetry Screening Workgroup. Pulse oximetry for critical congenital heart defects: a European consensus statement. Lancet Child Adolesc Health. 2017;1(2):88.
26. Marshall M. Radiographic assessment of umbilical venous and arterial catheter tip location. Neonatal Netw. 2014;33(4):208.
27. Masilamani K, van der Voort J. The management of acute hyperkalemia in neonates and children. Arch Dis Child. 2012;97(4):376.
28. McCay AS, Elliott EC, Walden M. Videos in clinical medicine. PICC placement in the neonate. N Engl J Med. 2014;370(11):e17.
CHAPTER 7 Physiologic Monitoring
https://t.me/medicina_free
185
29. Min SR, Lee HS. Compar ison of Wright’s formula and the Dunn method for measuring the umbilical arterial catheter insertion length. Pediatr Neonatol. 2015;56(2):120.
30. Morgan J, Bombell S, McGuire W. Early trophic feeding versus enteral fasting for very preterm or very low birth weight infants. Cochrane Database Syst Rev. 2013;3:CD000504.
31. Monagle P, Chalmers E, Chan A, et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians evidence-based clinical practice guidelines. 9th ed. Chest. 2012;141(suppl 2):e737S.
32. Neopenda. Wearable vital sign monitor for newborns. Available at:
www.neopenda.com. Accessed October 1, 2018.
33. O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the Prevention of Intravascular Catheter-Related Infections. CDC; 2011. Available at: www.cdc.gov/hicpac/pdf/guidelines/bsi-guide-
lines-2011.pdf. Accessed October 1, 2018.
34. Park CK, Paes BA, Nagel K, et al. Neonatal central venous catheter thrombosis: diagnosis, management and outcome. Blood Coagul Fibrinolysis. 2014;25(2):97.
35. Partridge EA, Davey MG, Hornick MA, et al. An extra-uterine system to physiologically support the extreme premature lamb. Nature Communications. 2017;8:15112. Available at: www.nature.
com/articles/ncomms15112.epdf?. Accessed October 1, 2018.
36. Restrepo RD, Hirst KR, Wittnebel L, Wettstein R. AARC clinical practice guideline: transcutaneous monitoring of carbon dioxide and oxygen. Respir Care. 2012;57(11):1955.
37. Robinson C, Gund A, Sjoqvist BA, Bry K. Using telemedicine in the care of newborn infants after discharge from a neonatal intensive care unit reduced the need for hospital visits. Acta Paediatr. 2016;105(8):902.
38. Rubortone SA, DeCarolis MP, Lacerenza S, et al. Use of a com­bined SpO2/PtcCO2 sensor in the delivery room. Sensors (Basel). 2012;12(8):10980.
39. Ross PA, Newth CJ, Khemani RG. Accuracy of pulse oximetry in children. Pediatrics. 2014;133(1):22.
40. Salley-Randall K, Tinkler S. Every NICU is a neuroNICU. Natl Assoc Neonatal Nurses (NANN) Conference. 2017.
41. Sanchez Luna M, Perez Munuzuri A, Sanz Lopez E, et al, Comite de Estandares de la Sociedad Espanola de Neonatologia. Pulse oximetry screening of critical congenital heart defects in
the neonatal period. The Spanish National Neonatal Society recommendations. An Pediatr (Barc). 2018;88(2):112.
42. Saxena A, Mehta A, Ramakrishnan S, et al. Pulse oximetry as a screening tool for detecting major congenital heart de­fects in Indian newborns. Arch Dis Child Fetal Neonatal Ed. 2015;100(5):F416.
43. Sharpe E, Pettit J, Ellsbury DL. A national survey of neonatal peripherally inserted central catheter (PICC) practices. Adv Neonatal Care. 2013;13(1):55.
44. Silverman DG, Banack T. Patient monitoring: wide potential for non-invasive brain temperature monitoring system. ASA Monitor. 2018;82:18.
45. Smith L, Dills R. Survey of medication administration through umbilical arterial and venous catheters. Am J Health Syst Pharm. 2003;60(15):1569.
46. Sood BG, McLaughlin K, Cortez J. Near-infrared spec­troscopy: application in neonates. Sem Fetal Neonatal Med. 2015;20(3):164.
47. Tingay DG, Mun KS, Perkins EJ. End tidal carbon dioxide is as reliable as transcutaneous monitoring in ventilated postsurgical neonates. Arch Dis Child Fetal Neonatal Ed. 2013;98(2):F161.
48. U.S. Department of Health and Human Services (USDHHS), Discretionary Advisory Committee on Heritable Disorders in Newborns and Children. Recommended Uniform Screening Panel. Updated July 2018. Available at: www.hrsa.gov/advisory-com-
mittees/heritable-disorders/rusp/index.html. Accessed October
1, 2018.
49. Usuda H, Watanabe S, Miura Y, et al. Successful maintenance of key physiological parameters in preterm lambs treated with ex vivo uterine therapy for a period of 1 week. Am J Obstet Gynecol. 2017;217(4):457.
50. Wang SK, Callaway NF, Wallenstein MB, et al. SUNDROP: six years of screening for retinopathy of prematurity with telemedi­cine. Can J Opthalmol. 2015;50(2):101.
51. Wenger TL, Gerdes J, Taub K, et al. Telemedicine for genetic and neurologic evaluation in the neonatal intensive care unit. J Perinatol. 2014;34(3):234.
52. Wyckoff MM, Sharpe EL, eds. Peripherally Inserted Central Catheters: Guidelines For Practice. 3rd ed. Chicago, IL: National Association of Neonatal Nurses; 2015.
ACID-BASE HOMEOSTASIS
pH = − log [H+]
pH = − log [0.0000001]
pH = − [–7]
pH=7
base
https://t.me/medicina_free
8
AND OXYGENATION
JAMES S. BARRY, JANE DEACON, CARMEN HERNANDEZ, AND M. DOUGLAS JONES, JR.
ccurate interpretation of blood gas val­ues and an understanding of acid-base
A
and oxygenation physiology are essential to the proper diagnosis or management of an ill neonate. blood gases allows an analysis of two interre­lated but separate processes: acid-base homeo­stasis and oxygen-carrying capacity.
chapter considers the parameters that describe these processes, their measurements, and the effects of proposed treatment on homeostasis. abbreviations and their meanings are listed in
Box 8.1.
Components of arterial blood gases include (1) measured values (Pao2, Paco2, and pH) and (2) cal­culated values (oxygen saturation, bicarbonate con­centration, and base excess). Some analyzer systems also estimate hemoglobin concentration. The pH,
Paco2, base excess, and bicarbonate components are used to assess acid-base homeostasis, whereas Pao2, saturation (Sao2), and hemoglo­bin concentration quacy of oxygen-carrying capacity (Table 8.1).
9,33,53
The measurement of arterial
1,53
Common
1,9
are used to assess the ade-
1,32,44
This
32,44,56
PHYSIOLOGY
Acid-Base Homeostasis
To review basic chemistry, an acid is a hydro­gen ion donor, and a base is a hydrogen ion acceptor. The pH refers to the concentration of hydrogen ions [H+] in a liquid and reflects the acid-base balance in liquid.56 The quantity of
hydrogen ions is minute, approximately 0.0000001 mole/L. Therefore, the negative log of the hydrogen ion concentration is used to define pH and create a
positive, workable number (pH = 7) (Equation 1).
A pH of 7 represents a neutral solution, a pH of less than 7 represents acidity, and a pH of greater than 7 represents alkalinity:
(1)
The Henderson-Hasselbalch equation describes pH as equal to a constant (pK) plus the logarithm of the ratio of the base-to-acid concentration (Equation 2). concentration of hydrogen ions (reflected in the denominator), the blood pH value decreases, and acidemia results. Conversely, if there is less acid or more base, the blood pH increases, and alkalemia results.
The first step in determining acid-base homeostasis is the measurement of pH. The normal human pH is between 7.35 and 7.45. Acidemia and acidosis are often used interchangeably, but strictly speaking, a pH of less than 7.35 is acidemia, and the process that caused it is acidosis; a pH of greater than 7.45 is alkalemia, and the process that caused it is alkalosis.33 Arterial carbon
dioxide (Paco2) and bicarbonate [HCO represent the two main components of acid­base homeostasis: (1) the respiratory contribution (Paco2) controlled by alveolar ventilation (2) the nonrespiratory or metabolic contribution controlled primarily by renal excretion, retention, or production of HCO
affect the nonrespiratory components of acid-base
10,36
Thus, if there is an increase in the
10
pH = pK + log
–.1,30,50
3
/
(2)
acid
3
1,17,20
Other factors that
–
] values
and
BLUE type highlights content that is particularly applicable to clinical settings.
186
CHAPTER 8 Acid-Base Homeostasis and Oxygenation
CO
co
o
o
o
o
https://t.me/medicina_free
187
BOX
8.1
A Alveolar a Arterial D Difference F Fraction I Inhalation, inspired P Partial pressure (tension, driving force) pH Negative log of hydrogen ion concentration
ABBREVIATIONS
Combined Abbreviations
Pa
Partial pressure of arterial oxygen
2
Fi
Fraction of inspired oxygen
2
Pi
Partial pressure of inspired oxygen
2
P50 Partial pressure at which hemoglobin is 50% saturated
balance cause a change in [HCO
–
]; thus, [HCO
3
an indicator of the nonrespiratory component.
–
3
30,35,50
] is
RESPIRATORY CONTRIBUTION
Carbon dioxide is produced from cellular
metabolism.
1,46
As carbon dioxide is produced, it dissolves in intracellular fluid and can be mea­sured as the partial pressure (P) of the dissolved gas (CO2). As the pressure of the dissolved gas increases inside the cell, carbon dioxide moves out of the cell and into the blood. Blood transports dissolved carbon dioxide (some combined with hemoglobin as carboxyhemoglobin, most as bicarbonate) to the lung, where the partial pressure in the pulmo­nary capillary is greater than that in the alveoli,43 causing carbon dioxide to move into the alveoli down a concentration gradient. Ventilation is the
only method of removing carbon dioxide. The amount of carbon dioxide in the blood is the net result of the body’s metabolism (production) and alveolar ventilation (clearance). Because
metabolism does not change greatly and CO2 dif­fuses easily across membranes, the only clinically important limitation to CO2 removal is at the lungs.
Thus, Paco2 reflects alveolar ventilation.
10,17,20,33
In the red blood cell, the enzyme carbonic anhy- drase promotes the combination of a fraction of dissolved CO2 with water to form carbonic acid (H2CO3), which then dissociates into a hydrogen ion [H+] and a bicarbonate ion [HCO
+ H2O = CO3 = [H+] + [HCO
2
2
–]1,46
3
–
]H
3
(3)
TABLE
8.1
BLOOD GASES VALUES
pH 7.35–7.45 Pa HCO Base excess (–5) to (+5) Pa O2 saturation 92%–94%
NORMAL (ARTERIAL) BLOOD GAS VALUES
2
–
3
2
35-45 mm Hg 18-26 mEq/L
60–80 mm Hg
Therefore, an increase in Paco2 (hypoventila-
tion) causes pH to fall. This is called respiratory acidosis.17 A decrease in Paco2 (hyperventilation) results in less acid formation in the blood and causes pH to rise. This pathophysiologic process is known as respiratory alkalosis.
NONRESPIRATORY (METABOLIC) CONTRIBUTION
Nonrespiratory (metabolic) derangements can also disturb acid-base homeostasis. Normal metabolism produces hydrogen ions. Blood pH is maintained
within normal limits by renal mechanisms for excreting hydrogen ions. Increased production of [H+] may occur in conditions such as shock with poor peripheral tissue perfusion or genet­ically determined aberrations of metabolism.52
The hydrogen ions produced must be eliminated to avoid a fall in blood pH. Derangements also occur when hydrogen ions are lost (e.g., in gastric fluids) or when bicarbonate is lost (e.g., in diarrheal fluid or ileostomy drainage).
53
Authorities differ as to the best way to describe nonrespiratory derangements in acid-base status. The traditional approach relies on the measure­ment of pH, Pco2, and [HCO
–
]. An alternative
3
description is of acid-base status in terms of (1) strong ions (Na+, K+, Ca2+, Mg2+, Cl–), strong because they remain dissociated at normal human blood pH, and (2) weak acids (hemoglobin, albu­min, inorganic phosphate), weak because they are partially dissociated at the normal human blood pH. Blood pH in this conceptualization is a function of the difference between strong cat­ions and strong anions, the strong ion difference (SID). As an example, the alkalosis associated
188 UNIT TWO Support of the Neonate
pH – 6.1 + log (20/1.2)
pH = 6.1 + 1.3 = 7.4
https://t.me/medicina_free
with the loss of gastric fluid would be described exclusively in terms of the loss of [Cl–], with the loss of [H+] making no independent contribution to the resulting alkalemia. Advocates maintain that the measurement of SID leads to a greater understanding of the causes of nonrespiratory and mixed acid-base derangements.
16,24,29,46
Others favor staying with the traditional bicarbonate-cen­tered model.
15,34
The present discussion focuses on the traditional bicarbonate-centered approach. Readers are referred to recent reviews for compar­isons of the two methods.
A fall in blood [HCO
29,34
–
] might indicate that
3
bicarbonate, a base and therefore a hydrogen ion acceptor, has been used up by the addition of [H+]. As shown in Equation 3, a change in [HCO
–
]
3
might also reflect a change in Pco2. This difficulty is overcome in blood gas analyzers by correcting the Pco2 (graphically) to 40 mm Hg, yielding a “standard bicarbonate” concentration.46 The stan­dard bicarbonate concentration and the buffering properties of hemoglobin are combined in the concept of base excess (BE). BE is strictly defined
as the amount of base or acid that is needed to restore blood to a pH of 7.4 at a normal Pco2 of 40 and temperature of 37°C.2 A posi­tive value suggests a deficit of fixed (i.e., not volatile as with H2CO3) acid or an excess of base; a negative value indicates an excess of fixed acid or a deficit of base.46 An abnormal­ity of the standard bicarbonate concentration or BE indicates a process of nonrespiratory (metabolic) alkalosis30 or nonrespiratory (met­abolic) acidosis.49 Caution is needed because
various blood gas analyzers do not calculate BE in a similar manner and can vary by 3 to 9 mmol/L.2 Additionally, BE is commonly calculated using assumptions from adult physiology with a normal bicarbonate of 26, which is significantly higher than what would be considered normal for a pre­mature neonate.
39
In the Henderson-Hasselbalch equation (see Equation 2), the pH is equal to a constant, pK, plus the logarithm of the base:acid ratio. tuting [HCO the acid
–
] for the base and dissolved CO2 for
3
17,46
and multiplying CO2 by its solubility
1,33,46
By substi-
coefficient (0.03 mEq/L/mm Hg), the equation becomes the following:
pH = pK + log [HCO
–
/ (Pco2 × 0.03)]
3
(4)
The value of pK is 6.1; the normal [HCO
3
–
] is
24 mEq/L, and the normal Paco2 is 40 mm Hg.
Substituting, we obtain the following:
(5)
or
Changes in the 20:1.2 ratio have profound effects
on the pH.
1. Hypoventilation of sufficient degree that Paco2 is doubled from 40 to 80 (respiratory acidosis) results in a ratio of 24:2.4, or 10. The logarithm of 10 is 1, and the pH would be 6.1 + 1, or 7.1.
2. If a metabolic acidosis reduced [HCO to 12 mEq/L, the ratio would be 12:1.2 or 10:1, and the pH would be 7.1.
MIXED CONTRIBUTIONS
The two most common reasons for acid-base disturbance in humans are the accumulation of carbon dioxide and the production of lactic acid through anaerobic metabolism as a conse­quence of tissue oxygen deprivation. Thus far,
these derangements (Fig. 8.1) have been discussed as if they happened in isolation, but respiratory and nonrespiratory problems often occur simulta­neously depending on pathologic processes in the body. Besides the four single acid-base derange-
ments, there are combined acid-base derange­ments: (1) respiratory acidosis and metabolic acidosis, (2) respiratory acidosis and metabolic alkalosis, (3) respiratory alkalosis and meta­bolic acidosis, and (4) respiratory alkalosis and metabolic alkalosis. The combined acidoses or
combined alkaloses have a cumulative effect on the pH, whereas a combination of acidosis and alkalosis tends to negate the effects of each on the pH value.
COMPENSATION
Acid-base homeostasis maintains pH near the nor-
mal range. The body attempts to maintain equi-
librium by balancing a pathologic process with a physiologic process or predictable buffering response.
nonrespiratory components of the acid-base system are deranged, the other system will compensate to counterbalance the primary process. For example, any respiratory process that leads to retention of car­bon dioxide (respiratory acidosis) stimulates a non­respiratory system, in this case the renal system, to
1,29
The following are two examples:
32,33,44,56
10,33,53
Thus, if either the respiratory or
–
] from 24
3